XML 37 R16.htm IDEA: XBRL DOCUMENT v3.21.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of Service Fee Revenue
Our total service revenues during the three and nine months ended September 30, 2021 and 2020 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):
 Three Months Ended
September 30,
Nine Months Ended
September 30,
2021202020212020
Commercial insurance$185,723 $160,524 $555,355 $412,415 
Medicare73,163 62,704 207,977 154,847 
Medicaid8,707 7,098 26,198 18,072 
Workers' compensation/personal injury11,554 7,183 32,507 25,705 
Other patient revenue4,800 8,328 14,766 17,211 
Management fee revenue5,255 2,675 16,007 8,574 
Teleradiology and Software revenue2,564 2,349 7,611 8,319 
Other3,641 5,869 10,058 15,617 
Service fee revenue295,407 256,730 870,479 660,760 
Revenue under capitation arrangements37,283 35,046 111,449 103,145 
Total service revenue$332,690 $291,776 $981,928 $763,905 
Schedule of Goodwill and Other Intangible Assets Activity in goodwill for the nine months ended September 30, 2021 is provided below (in thousands):
Balance as of December 31, 2020$472,879 
Goodwill acquired through acquisitions29,754 
Goodwill attributable to formation of Simi Valley Imaging Group LLC105 
Other Adjustments(28)
Balance as of September 30, 2021$502,710 
Schedule of Effect of Derivative Instruments on Comprehensive Loss A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):
For the three months ended September 30, 2021
AccountJune 30, 2021 BalanceAmount of comprehensive loss recognized on derivative net of taxesAmount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxesSeptember 30, 2021 BalanceLocation
Accumulated Other Comprehensive Loss, net of taxes$(20,736)$— $920 $(19,816)Equity

For the nine months ended September 30, 2021
AccountDecember 31, 2020 BalanceAmount of comprehensive loss recognized on derivative net of taxesAmount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxesSeptember 30, 2021 BalanceLocation
Accumulated Other Comprehensive Loss, net of taxes$(22,581)$— $2,765 $(19,816)Equity

A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):
For the three months ended September 30, 2021
Ineffective interest rate swapAmount of gain recognized in income on derivative (current period ineffective portion)Location of gain recognized in Income on derivative (current period ineffective portion)Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)Location of loss reclassified from accumulated OCI into income (prior period effective portion)
Interest rate contracts$2,870 Other income (expense)$(1,245)Interest Expense

For the nine months ended September 30, 2021
Ineffective interest rate swapAmount of gain recognized in income on derivative (current period ineffective portion)Location of gain recognized in Income on derivative (current period ineffective portion)Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)Location of loss reclassified from accumulated OCI into income (prior period effective portion)
Interest rate contracts$14,149 Other income (expense)$(3,735)Interest Expense
Schedule of Fair Value of Assets and Liabilities
The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):
 As of September 30, 2021
Level 1Level 2Level 3Total
Current and long term liabilities    
2019 Swaps - Interest Rate Contracts$— $23,839 $— $23,839 
 As of December 31, 2020
Level 1Level 2Level 3Total
Current and long term liabilities    
2019 Swaps - Interest Rate Contracts$— $37,989 $— $37,989 
The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):
 As of September 30, 2021
Level 1Level 2Level 3Total Fair ValueTotal Face Value
First Lien Term Loans and SunTrust Term Loan$— $769,380 $— $769,380 $771,188 
 As of December 31, 2020
Level 1Level 2Level 3Total Fair ValueTotal Face Value
First Lien Term Loans and SunTrust Term Loan$— $661,640 $— $661,640 $662,403 
Schedule of Earnings Per Share Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):
 Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
Net income (loss) attributable to RadNet, Inc.'s common stockholders$16,220 $6,156 $28,550 $(20,797)
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period52,810,644 51,358,603 52,323,360 50,746,380 
Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders$0.31 $0.12 $0.55 $(0.41)
DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period52,810,644 51,358,603 52,323,360 50,746,380 
Add nonvested restricted stock subject only to service vesting271,964 120,605 242,523 — 
Add additional shares issuable upon exercise of stock options and warrants735,232 476,607 683,815 — 
Weighted average number of common shares used in calculating diluted net income per share53,817,840 51,955,815 53,249,698 50,746,380 
Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders$0.30 $0.12 $0.54 $(0.41)
Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:
Nonvested restricted stock subject to service vesting— — — 331,659 
Shares issuable upon the exercise of stock options:— 48,948 — 933,370 
Schedule of Investment in Joint Ventures
The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2021 (in thousands):
Balance as of December 31, 2020$34,528 
Equity in earnings in these joint ventures8,259 
Equity contributions in existing joint ventures1,441 
Balance as of September 30, 2021$44,228 
Schedule of Joint Venture Investment and Financial Information
The following table is a summary of key balance sheet data for these joint ventures as of September 30, 2021 and December 31, 2020 and income statement data for the nine months ended September 30, 2021 and 2020 (in thousands):
Balance Sheet Data:September 30, 2021December 31, 2020
Current assets$46,186 $27,085 
Noncurrent assets67,514 68,686 
Current liabilities(12,182)(12,545)
Noncurrent liabilities(20,914)(21,582)
Total net assets$80,604 $61,644 
Book value of RadNet joint venture interests$36,940 $28,079 
Cost in excess of book value of acquired joint venture interests and other7,288 6,449 
Total value of RadNet joint venture interests$44,228 $34,528 
Income statement data for the nine months ended September 30,
20212020
Net revenue$98,193 $78,988 
Net income$16,007 $13,651